What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Study type: Phase 2b randomized clinical trial Participants: 272 adults with type 2 diabetes, average age 50.8, from 37 sites in China Published in: Annals of Internal Medicine , June 30, 2026 (DOI: 10.7326/ANNALS-25-04623) What it found: Biweekly bofanglutide produced HbA1c reductions and weight loss comparable to weekly semaglutide in Chinese patients with type 2 diabetes What it did not prove: The trial was not conducted in U.S
[DOI] [PubMed] [Google Scholar] 123.Afshin A., Forouzanfar M.H., Reitsma M.B., Sur P., Estep K., Lee A., Marczak L., Mokdad A.H., Moradi-Lakeh M., Naghavi M., et al
Well clearly outline all costs during your consultation.
March 23, 2023 Update: Hello Alpha no longer offers compounded GLP-1 medications (semaglutide or tirzepatide)
A study on broiler breeder roosters investigated the effect of ellagic acid-loaded liposomes on post-thaw sperm quality (141)
We keep expectations realistic and put your safety first, which is why the medication is always paired with medical oversight